Shareholder alert: ademi llp investigates whether seagen inc. has obtained a fair price in its transaction with pfizer

Milwaukee , march 13, 2023 /prnewswire/ -- ademi llp is investigating seagen (nasdaq: sgen) for possible breaches of fiduciary duty and other violations of law in its transaction with pfizer.  click here to learn how to join the action https://www.ademilaw.com/case/seagen-inc or call guri ademi toll-free at 866-264-3995.
SGEN Ratings Summary
SGEN Quant Ranking